n
A drug once investigated as a possible antidepressant.
n
(pharmacology) A tricyclic antidepressant, never marketed.
n
A drug that acts as a selective agonist for the β₃ adrenergic receptor, with antidepressant and anxiolytic effects.
n
An atypical tricyclic antidepressant.
n
(pharmacology) An antidepressant drug; a tablet containing this drug.
n
A tricyclic antidepressant that is an analogue and metabolite of amitriptyline.
n
Alternative spelling of amitriptyline [(pharmacology) An antidepressant drug; a tablet containing this drug.]
n
(pharmacology) An antidepressant drug of the tricyclic class.
n
(informal) antidepressant
n
A drug that acts as a partial agonist selective for the dopamine receptor D2.
n
(pharmacology) A stimulant-like drug, an active enantiomer of modafinil, being investigated for the treatment of various conditions such as depression, fatigue, and schizophrenia.
n
An antidepressant drug, developed in the 1980s but never marketed.
n
A tricyclic compound with antidepressant and antihypertensive effects.
n
(pharmacology) A tetracyclic antidepressant drug, developed in the 1970s but never marketed.
n
A monoamine oxidase inhibitor being investigated for the treatment of depression.
n
(pharmacology) A particular analgesic drug.
n
A particular arylcyclohexylamine that acts as a psychostimulant.
n
(pharmacology) 1-diaminoethylreserpine, a derivative of reserpine used as an antihypertensive agent.
n
A drug investigated as an antidepressant in the 1980s but never marketed.
n
A reversible inhibitor of monoamine oxidase A, used in the treatment of depression and anxiety.
n
(pharmacology) A drug used as a spasmolytic and otoneuroprotective agent.
n
(pharmacology) A tricyclic antidepressant, 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[b,f]azepine-3-carbonitrile, related to imipramine.
n
A tetracyclic antidepressant and anorectic drug, developed in the 1970s but never marketed.
n
(pharmacology) A tetracyclic antidepressant, never marketed.
n
(pharmacology) An antidepressant drug.
n
A hydrazine-derived antidepressant, never marketed.
n
A tricyclic antidepressant, never marketed.
n
An opioid analgesic of the morphinan family.
n
An antidepressant drug of the 1970s, never marketed.
n
An NMDA antagonist and SSRI with neuroprotective effects, being investigated as an antidepressant.
n
(pharmacology) A tricyclic antidepressant.
n
(pharmacology) A monoamine oxidase inhibitor C₁₃H₁₇N used especially to treat Parkinson's disease.
n
(pharmacology) A tricyclic antidepressant C₁₈H₂₂N₂.
n
(pharmacology) A drug that functions as an SNRI and is administered orally chiefly in the form of its succinate C₁₆H₂₅NO₂·C₄H₆O₄·H₂O or fumarate C₁₆H₂₅NO₂·C₄H₄O₄ especially to treat depression. It is the primary active metabolite of venlafaxine. Its succinate is marketed under the trademark Pristiq.
n
A serotonergic anorectic drug used for weight loss in the 1990s, later withdrawn because of cardiovascular side-effects.
n
(pharmacology) A tricyclic antidepressant.
n
A nicotinic acetylcholine receptor agonist, selective for the ganglionic subtype.
n
(medicine) A combination of valproate and valproic acid used to treat bipolar disorder
n
A hydrazine derivative MAOI antidepressant.
n
A particular tricyclic antidepressant.
n
(pharmacology) A psychotropic agent with tricyclic antidepressant and anxiolytic properties.
n
Alternative form of doxepin [(pharmacology) A psychotropic agent with tricyclic antidepressant and anxiolytic properties.]
n
(pharmacology, UK) A stimulant made from dextroamphetamine and amobarbital.
n
(pharmacology) A drug that functions as an SNRI and is administered orally in the form of its hydrochloride C₁₈H₁₉NOS·HCl especially to treat depression, anxiety, and chronic pain (such as that associated with fibromyalgia and peripheral neuropathy). It is marketed under the trademark Cymbalta.
n
A selective 5-HT_(1A) receptor agonist.
n
(pharmacology) A tricyclic antidepressant.
n
A dopamine agonist of the ergoline class.
n
An experimental drug formerly being developed for the treatment of insomnia.
n
(pharmacology) A drug that functions as an SSRI and is administered orally in the form of its oxalate C₂₀H₂₁FN₂O·C₂H₂O₄ to treat depression and anxiety.
n
(pharmacology) A selective norepinephrine reuptake inhibitor.
n
An experimental antidepressant drug.
n
(pharmacology) An antidepressant drug.
n
A drug with sedative and antipsychotic effects.
n
(pharmacology) An SSRI related to paroxetine.
n
A psychoactive piperazine drug formerly used as a nootropic.
n
A tricyclic antidepressant and antipsychotic drug, never marketed.
n
(pharmacology) A synthetic compound which inhibits the uptake of serotonin in the brain and is taken to treat depression.
n
A tricyclic antidepressant with neuroleptic properties.
n
(pharmacology) A first-generation antihistamine of the piperazine class, used as an antihistamine, antiemetic, anxiolytic, and weak analgesic.
n
(pharmacology) A selective serotonin reuptake inhibitor.
n
(pharmacology) A synthetic compound (trademark Tofranil) used to treat depression.
n
A tricyclic antidepressant that is an analogue and metabolite of imipramine.
n
A selective serotonin reuptake inhibitor marketed in 1983 as an antidepressant but swiftly withdrawn when found to cause neutropenia.
n
(pharmacology) A nonselective monoamine reuptake inhibitor that has been shown to block the reuptake of dopamine, norepinephrine, and serotonin with effects similar to those of cocaine.
n
(neurology) serotonin and proton pump stimulators
n
A tricyclic antidepressant.
n
A phenyltropane compound used in neuroimaging.
n
A tricyclic antidepressant.
n
An azapirone with anxiolytic and antidepressant properties.
n
(pharmacology) An antidepressant drug C₁₂H₁₃N₃O₂.
n
A serotonin antagonist used as an antihypertensive agent.
n
(pharmacology) A tricyclic antidepressant.
n
(pharmacology) Alternative form of ketimipramine. [(pharmacology) A tricyclic antidepressant.]
n
Alternative form of ʟ-dopa [(pharmacology) The levorotatory form of dopa, used to treat Parkinson's disease.]
n
(pharmacology) A serotonin and norepinephrine reuptake inhibitor used to treat major depressive disorders.
n
(pharmacology) An 5-HT₄ antagonist.
n
(chemistry, pharmacology) An antimanic drug that possesses a neurotropic activity similar to that of lithium carbonate.
n
(pharmacology) An antidepressant drug.
n
A tricyclic antidepressant drug, never marketed.
n
(pharmacology) A tricyclic antidepressant.
n
A tricyclic antidepressant.
n
An NDRI developed from radafaxine.
n
Alternative form of mebhydrolin [A particular antihistamine drug.]
n
(medicine) A drug, derived from adamantane, that is used to treat Alzheimer's disease, dementia etc.
n
(pharmacology) A phenylpiperazine tranquilizer.
n
Alternative form of methyprylon [A piperidinedione sedative used for treating insomnia, now less commonly prescribed because of its side effects.]
n
(pharmacology) A tricyclic antidepressant.
n
A tetracyclic antidepressant with antihistaminic and hypnosedative properties.
n
(pharmacology) A psychoactive drug, an SNRI antidepressant also used to treat chronic pain, especially fibromyalgia.
n
(pharmacology) An antidepressant drug C₁₇H₁₉N₃ taken orally especially to treat major depressive disorder. It is marketed under the trademark Remeron.
n
An antidepressant, anxiolytic, and antipsychotic drug.
n
(pharmacology) A serotoninergic modulating antidepressant that is used in therapy of depression, aggressive behavior and panic disorder.
n
A certain vaptan drug originally proposed for the treatment of anxiety and depression but whose development was halted in 2008.
n
A tricyclic antidepressant, also indicated for the treatment of nocturnal enuresis.
n
A tricyclic antidepressant used in the treatment of major depression, childhood bedwetting, and certain chronic illnesses.
n
(medicine) A tricyclic antidepressant
n
A tricyclic antidepressant.
n
A tricyclic antidepressant.
n
(pharmacology) An antidepressant.
n
A psychoactive drug used as an anxiolytic and antidepressant.
n
An antidepressant and anxiolytic drug.
n
An anxiolytic and muscle relaxant.
n
A psychoactive drug and research chemical of the tetracyclic chemical class.
n
A nootropic drug of the racetam family.
n
A tricyclic anticonvulsant.
n
(pharmacology) A withdrawn drug once used as a laxative.
n
(pharmacology) 9-hydroxyrisperidone, an atypical antipsychotic drug.
n
The antidepressant drug paroxetine.
n
A cough suppressant drug.
n
A tricyclic antidepressant.
n
A mild stimulant of the central nervous system, used to treat obesity, narcolepsy, ADHD and dementia, but no longer widely used because of the potential for abuse.
n
A tricyclic SSRI, structurally related to tandamine.
n
The succinic acid ester of pyridoxine and of deanol, used to treat mild cognitive impairment, fatigue, and depression.
n
An anticholinergic and antihistamine used as an antiparkinsonian agent.
n
A drug investigated as an antiallergen and antiasthmatic agent in the early 1980s but never marketed.
n
(pharmacology) An antidepressant and anxiolytic drug.
n
A nootropic drug derived from piracetam.
n
An antidepressant drug, never marketed.
n
(pharmacology) An anticonvulsant drug chemically related (and partially metabolized) to phenobarbital, used in the treatment of epilepsy and essential (idiopathic) tremor.
n
A stimulant of norepinephrine-dopamine reuptake inhibitors.
n
(pharmacology) An anticholinergic drug used to treat overactive bladder.
n
(pharmacology) A tricyclic antidepressant.
n
(pharmacology) An anxiolytic drug.
n
A trade name for the drug fluoxetine.
n
A selective 5-HT2A receptor antagonist investigated as an insomnia treatment.
n
A psychoactive drug formerly used as a sedative.
n
A drug which acts as a dopamine agonist selective for the D2 subtype.
n
(pharmacology) A particular tricyclic antidepressant.
n
A metabolite of bupropion being investigated for treatment of restless leg syndrome and as an NDRI antidepressant.
n
(pharmacology) An antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD.
n
A serotonin antagonist with potential uses in treating many neurological disorders.
n
(medicine) A dopaminergic and serotonergic drug once used to treat schizophrenia
n
A drug that acts as a selective M₁ receptor partial agonist.
n
(pharmacology) A sedative and anxiolytic drug in the imidazopyridine family.
n
(pharmacology) Any of a class of drugs, such as fluoxetine or sertraline, that inhibit the uptake of serotonin in the central nervous system and are often used to treat certain mental illnesses, such as depression.
n
(pharmacology) An SSRI that is an active metabolite of fluoxetine.
n
(pharmacology) A selective serotonin reuptake inhibitor.
n
(pharmacology) An antidepressant drug C₁₇H₁₇NCl₂ administered in the form of its hydrochloride and acting to enhance serotonin activity.
n
A tetracyclic antidepressant.
n
(pharmacology) An antidepressant drug.
n
(medicine) Initialism of serotonin-specific reuptake inhibitor. [(pharmacology) A selective serotonin reuptake inhibitor.]
n
A drug designed to treat depression and anxiety.
n
A selective norepinephrine reuptake inhibitor which was researched for the management of depression in the 1960s and 1970s but never commercialized.
n
A selective norepinephrine reuptake inhibitor which was researched as an antidepressant in the 1960s and 1970s but never commercialized.
n
(pharmacology) A tricyclic antidepressant drug.
n
A tricyclic SSRI, developed in the 1970s as an antidepressant but never marketed.
n
(medicine) Initialism of tricyclic antidepressant.
n
(pharmacology) An antidepressant drug.
n
A heterocyclic antidepressant.
n
(pharmacology) An antidepressant drug that is an inhibitor of monoamine oxidase and is administered in the form of its sulfate (C₉H₁₁N)₂·H₂SO₄
n
(pharmacology) An antidepressant drug C₁₉H₂₂ClN₅O administered in the form of its hydrochloride.
n
(pharmacology) A tricyclic antidepressant with sedative and anxiolytic properties.
n
The pivaloyloxymethyl ester derivative of valproic acid, used as an anticonvulsant in the treatment of epilepsy.
n
A piperazine derivative, a potent and selective dopamine reuptake inhibitor.
n
A piperazine drug with possible applications as an antidepressant.
n
A bicyclic antidepressant, a morpholine derivative that acts as a selective norepinephrine reuptake inhibitor.
n
A highly selective 5-HT2A receptor antagonist with potential applications in treating psychosis, depression, and insomnia.
n
(pharmacology) A particular atypical antidepressant.
n
An antidepressant drug, developed in the 1970s but never marketed.
n
Alternative form of zimelidine [A pyridylallylamine, the first selective serotonin reuptake inhibitor antidepressant to be marketed, developed in the early 1980s and later banned due to serious neuropathy and hypersensitivity reactions.]
n
A pyridylallylamine, the first selective serotonin reuptake inhibitor antidepressant to be marketed, developed in the early 1980s and later banned due to serious neuropathy and hypersensitivity reactions.
n
The antidepressant medicine sertraline.
Note: Concept clusters like the one above are an experimental OneLook
feature. We've grouped words and phrases into thousands of clusters
based on a statistical analysis of how they are used in writing. Some
of the words and concepts may be vulgar or offensive. The names of the
clusters were written automatically and may not precisely describe
every word within the cluster; furthermore, the clusters may be
missing some entries that you'd normally associate with their
names. Click on a word to look it up on OneLook.
Our daily word games Threepeat and Compound Your Joy are going strong. Bookmark and enjoy!
Today's secret word is 9 letters and means "Restore or refill to former level." Can you find it?